Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:INSP
Previous Symbol
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares21,400,000
Market Cap$0.00
OptionableOptionable
Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions
What is Inspire Medical Systems' stock symbol?
Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."
How were Inspire Medical Systems' earnings last quarter?
Inspire Medical Systems (NASDAQ:INSP) released its quarterly earnings data on Tuesday, November, 6th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.13. The company earned $13.10 million during the quarter, compared to analysts' expectations of $12.86 million. The company's revenue for the quarter was up 79.9% compared to the same quarter last year. During the same period last year, the business earned ($3.42) earnings per share. View Inspire Medical Systems' Earnings History.
When is Inspire Medical Systems' next earnings date?
What guidance has Inspire Medical Systems issued on next quarter's earnings?
Inspire Medical Systems updated its FY 2018 earnings guidance on Tuesday, November, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $47.5-48 million, compared to the consensus revenue estimate of $44.17 million.
What price target have analysts set for INSP?
6 brokerages have issued 1-year price targets for Inspire Medical Systems' shares. Their forecasts range from $25.00 to $57.00. On average, they expect Inspire Medical Systems' share price to reach $39.6667 in the next year. This suggests that the stock has a possible downside of 13.6%. View Analyst Price Targets for Inspire Medical Systems.
What is the consensus analysts' recommendation for Inspire Medical Systems?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Inspire Medical Systems.
Has Inspire Medical Systems been receiving favorable news coverage?
News articles about INSP stock have been trending positive on Friday, InfoTrie reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Inspire Medical Systems earned a news impact score of 2.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the stock's share price in the near term.
Who are some of Inspire Medical Systems' key competitors?
Some companies that are related to Inspire Medical Systems include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Aurora Spine (ASG), Avacta Group (AVCT), Cannabix Technologies (BLOZF), Cochlear (COH), ConvaTec Group (CTEC), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Electromed (ELMD), Ellex Medical Lasers (ELXMF), Fisher & Paykel Healthcare (FPH), GI Dynamics (GID) and GN Store Nord A/S (GGNDF).
Who are Inspire Medical Systems' key executives?
Inspire Medical Systems' management team includes the folowing people:
- Mr. Tim Herbert, Chief Exec. Officer and Pres
- Mr. Richard Buchholz, Chief Financial Officer
- Mr. Randy Ban, Sr. VP of Sales and Marketing
- Mr. Sean Cleary, VP of Global Market Devel.
- Mr. Gary A. Goetzke, VP of Health Economics
When did Inspire Medical Systems IPO?
(INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.
When did the company's lock-up period expire?
Inspire Medical Systems' lock-up period expired on Tuesday, October 30th. Inspire Medical Systems had issued 6,750,000 shares in its initial public offering on May 3rd. The total size of the offering was $108,000,000 based on an initial share price of $16.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period.
Who are Inspire Medical Systems' major shareholders?
Inspire Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Franklin Resources Inc. (2.88%), BlackRock Inc. (2.56%), Citadel Advisors LLC (0.89%), Gilder Gagnon Howe & Co. LLC (0.71%), Osterweis Capital Management Inc. (0.52%) and American Century Companies Inc. (0.47%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.
Which institutional investors are selling Inspire Medical Systems stock?
INSP stock was sold by a variety of institutional investors in the last quarter, including Hodges Capital Management Inc., Wells Fargo & Company MN, EAM Investors LLC, BlackRock Inc., Pentwater Capital Management LP, JPMorgan Chase & Co. and JPMorgan Chase & Co.. View Insider Buying and Selling for Inspire Medical Systems.
Which institutional investors are buying Inspire Medical Systems stock?
INSP stock was bought by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Osterweis Capital Management Inc., American Century Companies Inc., Columbus Circle Investors, Bellevue Group AG, Franklin Resources Inc., Macquarie Group Ltd. and Credit Suisse AG. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
How do I buy shares of Inspire Medical Systems?
Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Inspire Medical Systems' stock price today?
One share of INSP stock can currently be purchased for approximately $45.91.
What is Inspire Medical Systems' official website?
MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
